Major Vascular Complications in Patients Undergoing Non-Cardiac Surgery: Magnitude of the Problem, Risk Prediction, Surveillance, and Prevention

Evidence-Based Cardiology: Third Edition

Volumn , Issue , 2010, Pages 47-62

  Devereaux, Philip J ^a   Chan, Matthew ^b   Eikelboom, John ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Major perioperative vascular complications; Noncardiac surgery; Prevention; Risk prediction; Surveillance

Indexed keywords

EID: 84887152015     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444309768.ch5     Document Type: Chapter

References (112)

1. Weiser T, Regenbogen S, Thompson K et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372 (9633): 139-44.
2. Lee T, Marcantonio E, Mangione C et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100 (10): 1043-9.
3. Devereaux P, Goldman L, Cook D, Gilbert K, Leslie K, Guyatt G. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 2005; 173 (6): 627-34.
4. Mangano D. Peri-operative cardiovascular morbidity: new developments. Bailli è re's Clin Anaesthesiol 1999; 13 (3): 335-48.
5. Devereaux P, Yang H, Yusuf S et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371 (9627): 1839-47.
6. Khuri S, Daley J, Henderson W et al. The National Veterans Administration Surgical Risk Study: risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg 1995; 180 (5): 519-31.
7. Kumar R, Mckinney W, Raj G et al. Adverse cardiac events after surgery: assessing risk in a veteran population. J Gen Intern Med 2001; 16 (8): 507-18.
8. The Global HIV/AIDS pandemic, 2006. Morb Mortal Wkly Rep 2006; 55 (31): 841-4.
9. Detsky A, Abrams H, Mclaughlin J et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986; 1 (4): 211-19.
10. Goldman L, Caldera D, Nussbaum S et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297 (16): 845-50.
11. Larsen S, Zaric D, Boysen G. Postoperative cerebrovascular accidents in general surgery. Acta Anaesthesiol Scand 1988; 32 (8): 698-701.
12. Landercasper J, Merz B, Cogbill T et al. Perioperative stroke risk in 173 consecutive patients with a past history of stroke. Arch Surg 1990; 125 (8): 986-9.
13. Parikh S, Cohen J. Perioperative stroke after general surgical procedures. NY State J Med 1993; 93 (3): 162-5.
14. Rockman C, Cappadona C, Riles T et al. Causes of the increased stroke rate after carotid endarterectomy in patients with previous strokes. Ann Vasc Surg 1997; 11 (1): 28-34.
15. Limburg M, Wijdicks E, Li H. Ischemic stroke after surgical procedures: clinical features, neuroimaging, and risk factors. Neurology 1998; 50 (4): 895-901.
16. Gilbert K, Larocque B, Patrick L. Prospective evaluation of cardiac risk indices for patients undergoing noncardiac surgery. Ann Intern Med 2000; 133 (5): 356-9.
17. Chan A, Livingstone D, Tu J. The Goldman and Detsky Cardiac-Risk Indices: do they work in patients undergoing hip-fracture surgery? Ann Rcpsc 1999; 32 (6): 337-41.
18. Devereaux PJ. Commentary on index identified patients at high risk of cardiac complications following non-urgent, non-cardiac surgical procedures. Evidence-Based Cardiovasc Med 2000; 4: 13.
19. Beattie W, Abdelnaem E, Wijeysundera D, Buckley D. A Meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg 2006; 102 (1): 8-16.
20. Vanzetto G, Machecourt J, Blendea D et al. Additive value of thallium single-photon emission computed tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol 1996; 77 (2): 143-8.
21. Coley C, Field T, Abraham S, Boucher C, Eagle K. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol 1992; 69 (16): 1280-5.
22. Brown K, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 1993; 21 (2): 325-30.
23. Boersma E, Poldermans D, Bax J et al. Predictors of cardiac events after major vascular surgery: role of clinical characteristics, dobutamine echocardiography, and beta-blocker therapy. JAMA 2001; 285 (14): 1865-73.
24. Poldermans D, Arnese M, Fioretti P et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. J Am Coll Cardiol 1995; 26 (3): 648-53.
25. Levin E, Gardner D, Samson W. Natriuretic peptides. N Engl J Med 1998; 339 (5): 321-8.
26. Goetze J, Christoffersen C, Perko M et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003; 17 (9): 1105-7.
27. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-Terminal Pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005; 352 (7): 666-75.
28. De Lemos J, Morrow D, Bentley J et al. The prognostic value Of B-type natriuretic peptide in patients with acute coronary syndromes . N Engl J Med 2001; 345 (14): 1014-21.
29. Tsutamoto T, Wada A, Maeda K et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96 (2): 509-16.
30. Berger R, Huelsman M, Strecker K et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105 (20): 2392-7.
31. Blankenberg S, Mcqueen M, Smieja M et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 2006; 114 (3): 201-8.
32. Dernellis J, Panaretou M. Assessment of cardiac risk before non-cardiac surgery: brain natriuretic peptide in 1590 patients. Heart 2006; 92 (11): 1645-50.
33. Feringa H, Bax J, Elhendy A et al. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass. Am J Cardiol 2006; 98 (1): 111-15.
34. Cuthbertson B, Amiri A, Croal B et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 2007; 99 (2): 170-6.
35. Cuthbertson B, Card G, Croal B, Mcneilly J, Hillis G. The utility of B-type natriuretic peptide in predicting postoperative cardiac events and mortality in patients undergoing major emergency non-cardiac surgery. Anaesthesia 2007; 62 (9): 875-81.
36. Cardinale D, Colombo A, Sandri M et al. Increased perioperative N-terminal pro-B-type natriuretic peptide levels predict atrial fibrillation after thoracic surgery for lung cancer. Circulation 2007; 115 (11): 1339-44.
37. Yun K, Jeong M, Oh S et al. Preoperative plasma N-terminal pro-brain natriuretic peptide concentration and perioperative cardiovascular risk in elderly patients. Circ J 2008; 72 (2): 195-9.
38. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation 1995; 92 (3): 657-71.
39. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983; 50 (2): 127-34.
40. Horie T, Sekiguchi M, Hirosawa K. Coronary thrombosis in pathogenesis of acute myocardial infarction. Histopathological study of coronary arteries in 108 necropsied cases using serial section. Br Heart J 1978; 40 (2): 153-61.
41. Sinapius D. [Relationship between coronary-artery thrombosis and myocardial infarction]. Dtsch Med Wochenschr 1972; 97 (12): 443-8.
42. Chapman I. Relationships of recent coronary artery occlusion and acute myocardial infarction. J Mt Sinai Hosp N Y 1968; 35 (2): 149-54.
43. Spain D. Pathologic spectrum of myocardial infarction. In: Likoff W, Segal B, Insull W et al, eds. Atherosclerosis And Coronary Heart Disease. New York: Grune and Stratton, 1972; 133-9.
44. Davies M, Woolf N, Robertson W. Pathology of acute myocardial infarction with particular reference to occulsive coronary thrombi. Br Heart J 1976; 38: 659-64.
45. Landesberg G. The pathophysiology of perioperative myocardial infarction: facts and perspectives. J Cardiothorac Vasc Anesth 2003; 17 (1): 90-100.
46. Dawood M, Gutpa D, Southern J, Walia A, Atkinson J, Eagle K. Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention. Int J Cardiol 1996; 57 (1): 37-44.
47. Cohen M, Aretz T. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol 1999; 8 (3): 133-9.
48. Von Kanel R, Dimsdale J. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol 2000; 65 (6): 357-69.
49. Von Kanel R, Mills P, Ziegler M, Dimsdale J. Effect Of beta2-adrenergic receptor functioning and increased norepinephrine on the hypercoagulable state with mental stress. Am Heart J 2002; 144 (1): 68-72.
50. Yun A, Lee P, Bazar K. Can thromboembolism be the result, rather than the inciting cause, of acute vascular events such as stroke, pulmonary embolism, mesenteric ischemia, and venous thrombosis? A maladaptation of the prehistoric trauma response. Med Hypotheses 2005; 64 (4): 706-16.
51. Hjemdahl P, Larsson P, Wallen N. Effects of stress and beta-blockade on platelet function. Circulation 1991; 84 (6 suppl): Vi 44-61.
52. Ellis S, Hertzer N, Young J, Brener S. Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol 1996; 77 (12): 1126-8.
53. Mcfalls E, Ward H, Moritz T et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004; 351 (27): 2795-804.
54. Devereaux P, Goldman L, Yusuf S, Gilbert K, Leslie K, Guyatt G. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. C MAJ 2005; 173 (7): 779-88.
55. Mangano D, Browner W, Hollenberg M, London M, Tubau J, Tateo I. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323 (26): 1781-8.
56. Ashton C, Petersen N, Wray N et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993; 118 (7): 504-10.
57. Badner N, Knill R, Brown J, Novick T, Gelb A. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88 (3): 572-8.
58. Filipovic M, Jeger R, Probst C et al. Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. J Am Coll Cardiol 2003; 42 (10): 1767-76.
59. Oscarsson A, Eintrei C, Anskar S et al. Troponin T-values provide long-term prognosis in elderly patients undergoing non-cardiac surgery. Acta Anaesthesiol Scand 2004; 48 (9): 1071-9.
60. Shah K, Kleinman B, Rao T, Jacobs H, Mestan K, Schaafsma M. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 1990; 70 (3): 240-7.
61. Devereaux P, De Beer J, Villar J et al. Perioperative myocardial infarction: a silent killer. CJGIM 2006; 1: 9-13.
62. Mangano D, Browner W, Hollenberg M, Li J, Tateo I. Long-term cardiac prognosis following noncardiac surgery. The Study of Perioperative Ischemia Research Group. JAMA 1992; 268 (2): 233-9.
63. Lopez-Jimenez F, Goldman L, Sacks D et al. Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol 1997; 29 (6): 1241-5.
64. Sear J, Giles J, Howard-Alpe G, Foex P. Perioperative beta-blockade, 2008: what does Poise tell us, and was our earlier caution justified? Br J Anaesth 2008; 101 (2): 135-8.
65. Stone J, Foex P, Sear J, Johnson L, Khambatta H, Triner L. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent. Anesthesiology 1988; 68 (4): 495-500.
66. Mangano D, Layug E, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335 (23): 1713-20.
67. Poldermans D, Boersma E, Bax J et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341 (24): 1789-94.
68. Palda V, Detsky A. Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med 1997; 127 (4): 313-28.
69. Eagle K, Berger P, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002; 105 (10): 1257-67.
70. Juul A, Wetterslev J, Gluud C e t al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ 2006; 332 (7556): 1482.
71. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol After Vascular Surgery (MAVS) study, a randomized controlled trial. Am Heart J 2006; 152 (5): 983-90.
72. Fleisher L, Beckman J, Brown K et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol 2007; 50 (17): 1707-32.
73. Devereaux PJ, Yang H, Guyatt G et al. Rationale, design, and organization of the Perioperative Ischemic Evaluation (Poise) trial: a randomized controlled trial of metoprolol versus placebo in patients undergoing noncardiac surgery. Am Heart J 2006; 152 (2): 223-30.
74. Bangalore S, Wetterslev J, Pranesh S, Sawhney S, Gluud C, Messerli F. Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis. Lancet 2008; 372 (9654): 1962-76.
75. Chen Z, Pan H, Chen Y et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005; 366 (9497): 1622-32.
76. Fleisher L, Poldermans D. Perioperative beta blockade: where do we go from here? Lancet 2008; 371 (9627): 1813-14.
77. Lindenauer P, Fitzgerald J, Hoople N, Benjamin E. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade. Arch Intern Med 2004; 164 (7): 762-6.
78. Schmidt M, Lindenauer P, Fitzgerald J, Benjamin E. Forecasting the impact of a clinical practice guideline for perioperative beta-blockers to reduce cardiovascular morbidity and mortality . Arch Intern Med 2002; 162 (1): 63-9.
79. Taylor R, Pagliarello G. Prophylactic beta-blockade to prevent myocardial infarction perioperatively in high-risk patients who undergo general surgical procedures. Can J Surg 2003; 46 (3): 216-22.
80. Muzi M, Goff D, Kampine J, Roerig D, Ebert T. Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology 1992; 77 (5): 864-71.
81. Dorman T, Clarkson K, Rosenfeld B, Shanholtz C, Lipsett P, Breslow M. Effects of clonidine on prolonged postoperative sympathetic response. Crit Care Med 1997; 25 (7): 1147-52.
82. Wijeysundera D, Naik J, Beattie W. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003; 114 (9): 742-52.
83. Ellis J, Drijvers G, Pedlow S et al. Premedication with oral and transdermal clonidine provides safe and efficacious postoperative sympatholysis. Anesth Analg 1994; 79 (6): 1133-40.
84. Wallace A, Galindez D, Salahieh A et al. Effect of clonidine on cardiovascular morbidity and mortality after noncardiac surgery. Anesthesiology 2004; 101 (2): 284-93.
85. Hidalgo M, Auzani J, Rumpel L, Moreira N Jr, Cursino A, Caumo W. The clinical effect of small oral clonidine doses on perioperative outcomes in patients undergoing abdominal hysterectomy . Anesth Analg 2005; 100 (3): 795-802.
86. Quintin L, Bouilloc X, Butin E et al. Clonidine for major vascular surgery in hypertensive patients: a double-blind, controlled, randomized study. Anesth Analg 1996; 83 (4): 687-95.
87. Ghignone M, Calvillo O, Quintin L. Anesthesia and hypertension: the effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anesthesiology 1987; 67 (1): 3-10.
88. Kranke P, Eberhart L, Roewer N, Tramer M. Pharmacological treatment of postoperative shivering: a quantitative systematic review of randomized controlled trials. Anesth Analg 2002; 94 (2): 453-60.
89. Nader N, Ignatowski T, Kurek C, Knight P, Spengler R. Clonidine suppresses plasma and cerebrospinal fluid concentrations of TNF-alpha during the perioperative period. Anesth Analg 2001; 93 (2): 363-9.
90. Quintin L, Viale J, Annat G et al. Oxygen uptake after major abdominal surgery: effect of clonidine. Anesthesiology 1991; 74 (2): 236-41.
91. Nishina K, Mikawa K, Uesugi T et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology 2002; 96 (2): 323-9.
92. Devereaux PJ, Beattie W, Choi P et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005; 331 (7512): 313-21.
93. Naesh O, Friis J, Hindberg I, Winther K. Platelet function in surgical stress. Thromb Haemost 1985; 54 (4): 849-52.
94. Beving H, Zhao C, Albage A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis 1996; 7 (1): 80-4.
95. Fatah K, Beving H, Albage A, Ivert T, Blomback M. Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient? Eur Heart J 1996; 17 (9): 1362-6.
96. Mcdaniel M, Pearce W, Yao J et al. Sequential changes in coagulation and platelet function following femorotibial bypass. J Vasc Surg 1984; 1 (2): 261-8.
97. Robless P, Mikhailidis D, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001; 88 (6): 787-800.
98. The PEP investigators. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355 (9212): 1295-302.
99. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324 (7329): 71-86.
100. O'Neil-Callahan K, Katsimaglis G, Tepper M et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (STARRS) study. J Am Coll Cardiol 2005; 45 (3): 336-42.
101. Kapoor A, Kanji H, Buckingham J, Devereaux PJ, Mcalister F. Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies. BMJ 2006; 333 (7579): 1149.
102. Redelmeier D, Thiruchelvam D, Daneman N. Delirium after elective surgery among elderly patients taking statins. CMAJ 2008; 179 (7): 645-52.
103. Redelmeier D. New thinking on postoperative delirium. CMAJ 2007; 177: 424.
104. Durazzo A, Machado F, Ikeoka D et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004; 39 (5): 967-75; discussion 975-6.
105. Dunkelgrun M, Boersma E, Gemert Ak-V et al. Abstract 4536: bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing non-cardiovascular surgery; a randomized controlled trial. Circulation 2008; 118:S 906-C 907.
106. Poldermans D, Schouten O, Benner R et al. Abstract 2886: fluvastatin XI Use is associated with improved cardiac outcome after major vascular surgery. Results from a randomized placebo controlled trial: decrease III. Circulation 2008; 118: S 792.
107. Hulten E, Jackson J, Douglas K, George S, Villines T. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166 (17): 1814-21.
108. Rigg J, Jamrozik K, Myles P et al. Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial. Lancet 2002; 359 (9314): 1276-82.
109. Rodgers A, Walker N, Schug S et al. Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ 2000; 321 (7275): 1493.
110. Beattie W, Badner N, Choi P. Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg 2001; 93 (4): 853-8.
111. Park W, Thompson J, Lee K. Effect of epidural anesthesia and analgesia on perioperative outcome: a randomized, controlled Veterans Affairs Cooperative study. Ann Surg 2001; 234 (4): 560-9; discussion 569-71.
112. Poldermans D, Schouten O, Vidakovic R et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the Decrease-V pilot study. J Am Coll Cardiol 2007; 49 (17): 1763-9.